Thought it would be useful to record analyst valuations...

Thought it would be useful to record analyst valuations somewhere central. Please update, correct or add any I have missed, have wrong or are out dated:

UBS have A2 as a buy at NZD$17.10
Macquarie have A2 as an outperform at AUD$16.70
Goldman Sachs have A2 as an outperform at NZD$17.50
Citi have A2 as a neutral at AUD$15.15
Morningstar have A2 as a hold at NZD$15

Even the two holds have A2 valued at prices significantly above where A2 is currently trading so also imply buys.

”According to a note out of Goldman Sachs, in August a2 Milk Company’s Tmall and Taobao sales grew 37% on the prior corresponding period.It said: “Baby formula category grew by 16% yoy. A2M continued to be the clear outperformer with 37% yoy growth, while Nutrilon and Wyeth underperformed.”

“Within the IMF space, flagship stores in the CBEC channel seemed to grow faster in general. A2, Aptamil and Bellamy’s showed the strongest growth, while Nutrilon seemed to lag,” the broker added.

Overall, this appears to show that a2 Milk Company has had a solid start to the year and looks well-positioned to deliver another strong result if it can continue this positive momentum.

Goldman appears confident it will and has reiterated its conviction buy rating and NZ$17.50 (A$16.11) price target on its shares.” (Motley Fool)

Of course, please always do your own research before acting...